Raicol crystals will develops new and improved c-o and non-linear optical materials. Leysop will characterise them and design into novel modulating, switching and deflecting devices, while aot will integrate them in new highly advanced laser products.
Development of a new product line, based on the pyrazolo-triazine motif, enhancing the sirna, aptamers and antisense activities as potential therapeutic tools.
The aim is to develop transparent conducting oxide nanostructured films by a pulsed laser deposition technique with multifunctional properties (hydrophobicty, scratch).
To build a 2-d laser system for material processing. There two main areas of innovation in the project: 1) development of a new type of high power laser ; 2) development of a very high performance linear motor; and 3) development of a high performance digital drive.
To develop chromatographic tools which will enable the rapid purification/concentration of large herpes virus vaccines. Developed process will facilitate downstream applications by increasing purity and potency.
Silvac aims at the development of silver nanocluster doped thin films obtained by standard coating techniques (pvd, cvd, sputtering, printing) on several substrates to improve their antibacterial activity. The first applications are on interiors surfaces such as internal doors, steering wheel, gear
A computer centric method for designing drug-like molecules using fragments will be developed by combining proprietary technology from acellera labs and hql pharmaceuticals. The methodology, will be validated by developing small molecule inhibitors of chemokines, biokine's field of expertise.
The scope of this project is the development of a new ultrafiltration reverse osmosis filtration process for water reuse with an emphasis on organic and biofouling control. This goal will be addressed using an integrated process including enhanced uf and ro membranes.